Manufacturer, Forest Labs, Inc. of Lexapro, a serotonin reuptake inhibitor drug that treats depression and generalized anxiety disorders are currently being sued for the correlation found in many studies of the drug Lexapro and Children with birth defects. According to the FDA, a study suggested that women who use an SSRI after their 20th week of pregnancy are at a higher risk of delivering infants with a life-threatening lung condition known as persistent pulmonary hypertension of the newborn (PPHN).Additional injuries include cranial, facial, and limb malformations, as well as serious heart and organ defects. According to the lawsuits, Forest Labs conducted tests on Lexapro and knew that the drug could cause congenital birth defects; however, the company failed to disclose these findings to the public and continued to market the antidepressant to expectant mothers and women of child-bearing age.
This is not a class action lawsuit. These lawsuits are being filed individually by women who took Lexapro during their pregnancies and gave birth to children with congenital defects. Most attorneys handling these lawsuits work on a contingency-fee basis. This means the lawyer will collect, in most cases, one-third of the award if the suit is successful. If the lawsuit is unsuccessful, the client will not have to pay the lawyer for any work done on the case.
Women who have filed lawsuits against Forest Labs allege that they gave birth to infants with the following birth defects:
- Hypoplastic Left Heart Syndrome
- Atrial or Ventricular Septal Defects
- Tetralogy of Fallot (TOF)
- Coarctation of the Aorta
- Persistent Pulmonary Hypertension of the Newborn (PPHN)
- Transposition of the Great Arteries (TGA)
- Club Foot
- Cleft Palate or Lip
- Anal Atresia
You may be entitled to compensation for:
- Hospital Bills
- Lost Income
- Pain and Suffering
- Wrongful death
- Other losses
For more information, Please contact the Pirl team today at (650) 762-8545 or fill out the form below!
*****A VITAL NOTE FROM THE PIRL TEAM: As we report on any medical product/medication case - NEVER STOP OR ALTER A MEDICAL PROGRAM OR COURSE OF MEDICATION WITHOUT CONSULTING YOUR(S) OR A PHYSICIAN.*****